Lisa Vandermeer

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 15

Top Topics

Positive Breast Cancer

General Practice

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Arif Ali Awan, Deanna Saunders, Gregory Pond, Caroline Hamm, Nadia Califaretti, Mihaela Mates, Vikaash Kumar, Mohammed F K Ibrahim, Ana-Alicia Beltran-Bless, Lisa Vandermeer, John Hilton, Mark J Clemons
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study. Current oncology (Toronto, Ont.) 31 (3) (2024)
Arif Ali Awan, Deanna Saunders, Gregory Pond, Caroline Hamm, Nadia Califaretti, Mihaela Mates, Vikaash Kumar, Mohammed F K Ibrahim, Ana-Alicia Beltran-Bless, Lisa Vandermeer, John Hilton, Mark J Clemons
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study. Current oncology (Toronto, Ont.) 31 (3) (2024)
Arif Ali Awan, Deanna Saunders, Gregory Pond, Caroline Hamm, Nadia Califaretti, Mihaela Mates, Vikaash Kumar, Mohammed F K Ibrahim, Ana-Alicia Beltran-Bless, Lisa Vandermeer, John Hilton, Mark J Clemons
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study. Current oncology (Toronto, Ont.) 31 (3) (2024)
Arif Ali Awan, Deanna Saunders, Gregory Pond, Caroline Hamm, Nadia Califaretti, Mihaela Mates, Vikaash Kumar, Mohammed F K Ibrahim, Ana-Alicia Beltran-Bless, Lisa Vandermeer, John Hilton, Mark J Clemons
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study. Current oncology (Toronto, Ont.) 31 (3) (2024)
Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark J Clemons, Sharon McGee
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective. Current oncology (Toronto, Ont.) 30 (12) (2023)
Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark J Clemons, Sharon McGee
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective. Current oncology (Toronto, Ont.) 30 (12) (2023)
Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark J Clemons, Sharon McGee
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective. Current oncology (Toronto, Ont.) 30 (12) (2023)
Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark J Clemons, Sharon McGee
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective. Current oncology (Toronto, Ont.) 30 (12) (2023)
Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark J Clemons, Sharon McGee
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective. Current oncology (Toronto, Ont.) 30 (12) (2023)
Michelle Bradbury, Marie-France Savard, Lisa Vandermeer, Lucas Clemons, Gregory Pond, John Hilton, Mark J Clemons, Sharon McGee
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective. Current oncology (Toronto, Ont.) 30 (12) (2023)
Bader Alshamsan, Brian Hutton, Michelle Liu, Lisa Vandermeer, Mark J Clemons
Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program. Current oncology (Toronto, Ont.) 29 (12) (2022)
Bader Alshamsan, Brian Hutton, Michelle Liu, Lisa Vandermeer, Mark J Clemons
Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program. Current oncology (Toronto, Ont.) 29 (12) (2022)
Bader Alshamsan, Brian Hutton, Michelle Liu, Lisa Vandermeer, Mark J Clemons
Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program. Current oncology (Toronto, Ont.) 29 (12) (2022)
Bader Alshamsan, Brian Hutton, Michelle Liu, Lisa Vandermeer, Mark J Clemons
Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program. Current oncology (Toronto, Ont.) 29 (12) (2022)
Bader Alshamsan, Brian Hutton, Michelle Liu, Lisa Vandermeer, Mark J Clemons
Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program. Current oncology (Toronto, Ont.) 29 (12) (2022)